IM Cannabis Corp.

NasdaqCM:IMCC Stock Report

Market Cap: US$1.8m

IM Cannabis Management

Management criteria checks 3/4

IM Cannabis' CEO is Oren Shuster, appointed in Oct 2019, has a tenure of 6.58 years. total yearly compensation is CA$526.40K, comprised of 100% salary and 0% bonuses, including company stock and options. directly owns 12.36% of the company’s shares, worth $221.62K. The average tenure of the management team and the board of directors is 4.8 years and 0.8 years respectively.

Key information

Oren Shuster

Chief executive officer

CA$526.4k

Total compensation

CEO salary percentage100.00%
CEO tenure6.6yrs
CEO ownership12.4%
Management average tenure4.8yrs
Board average tenureless than a year

Recent management updates

Recent updates

Analysis Article • Dec 17

IM Cannabis Corp. (NASDAQ:IMCC) Surges 40% Yet Its Low P/S Is No Reason For Excitement

IM Cannabis Corp. ( NASDAQ:IMCC ) shareholders are no doubt pleased to see that the share price has bounced 40% in the...
Analysis Article • Oct 30

IM Cannabis Corp. (NASDAQ:IMCC) Looks Inexpensive After Falling 28% But Perhaps Not Attractive Enough

Unfortunately for some shareholders, the IM Cannabis Corp. ( NASDAQ:IMCC ) share price has dived 28% in the last thirty...
Seeking Alpha • Sep 08

IM Cannabis Shareholder Rafael Gabay raises stake

IM Cannabis (NASDAQ:IMCC) Shareholder Rafael Gabay acquired an aggregate of 613,496 shares in the company at a price of $0.50 per share. The acquisition was a part of the company's non-brokered private placement of 4.9M shares for aggregate proceeds of $2.4M. Gabay, who held 8.1M shares, or 11.61% of the issued and outstanding shares, prior to the private placement, paid an aggregate cash consideration of $306K and now holds beneficial ownership of an aggregate of 8.7M shares, or ~ 11.67% of the issued and outstanding shares. Gabay has acquired the shares for general investment purposes. IMCC shares were trading +5.12% pre-market. Source: Press Release
Seeking Alpha • Aug 15

IM Cannabis GAAP EPS of -C$0.30, revenue of C$23.8M

IM Cannabis press release (NASDAQ:IMCC): Q2 GAAP EPS of -C$0.30. Revenue of C$23.8M (+114.2% Y/Y). Total dried flower sold for Q2 2022 was 3,210 kilograms at an average selling price of C$5.72 per gram, compared to 1,842 kilograms for the same period in 2021 at an average selling price of C$3.92 per gram.  Cash and cash equivalents totaled $5.86M as at June 30, 2022, compared to C$34.05M as at December 31, 2021.
Seeking Alpha • Jul 19

IM Cannabis receives non-compliance notification from Nasdaq for minimum bid price requirement

Nasdaq notified IM Cannabis (NASDAQ:IMCC) that it is not in compliance with the minimum bid price requirement. The notification does not impact the listing on Nasdaq and it has been provided 180 calendar days, or until Jan.9, 2023 to regain compliance with the rule.
Seeking Alpha • Aug 14

cbdMD And IM Cannabis Partner To Sell CBD Products In Israeli Markets

Israel is expected to pass legislation in September, legalizing CBD and decriminalizing cannabis. cbdMD has granted IM Cannabis the exclusive right to import and sell their CBD products in Israel. cbdMD reported Q3-2021 CBD revenues of $10.6M and operates at a net income. IM Cannabis reported Q1-2021 cannabis revenues of CA$7M and operates at a net income. I rate both companies as a neutral buy and recommend that investors watch their financial performance.

CEO Compensation Analysis

How has Oren Shuster's remuneration changed compared to IM Cannabis's earnings?
DateTotal CompensationSalaryCompany Earnings
Mar 31 2026n/an/a

-CA$14m

Dec 31 2025CA$526kCA$526k

-CA$11m

Sep 30 2025n/an/a

-CA$5m

Jun 30 2025n/an/a

-CA$2m

Mar 31 2025n/an/a

-CA$5m

Dec 31 2024CA$530kCA$485k

-CA$11m

Sep 30 2024n/an/a

-CA$13m

Jun 30 2024n/an/a

-CA$14m

Mar 31 2024n/an/a

-CA$15m

Dec 31 2023CA$808kCA$476k

-CA$9m

Sep 30 2023n/an/a

-CA$15m

Jun 30 2023n/an/a

-CA$17m

Mar 31 2023n/an/a

-CA$17m

Dec 31 2022CA$2mCA$506k

-CA$23m

Sep 30 2022n/an/a

-CA$22m

Jun 30 2022n/an/a

-CA$16m

Mar 31 2022n/an/a

-CA$10m

Dec 31 2021CA$2mCA$516k

CA$91k

Sep 30 2021n/an/a

-CA$10m

Jun 30 2021n/an/a

-CA$12m

Mar 31 2021n/an/a

-CA$24m

Dec 31 2020CA$742kCA$424k

-CA$29m

Sep 30 2020n/an/a

-CA$7m

Jun 30 2020n/an/a

-CA$10m

Mar 31 2020n/an/a

-CA$982k

Dec 31 2019CA$2mCA$357k

-CA$7m

Compensation vs Market: Oren's total compensation ($USD381.73K) is below average for companies of similar size in the US market ($USD631.70K).

Compensation vs Earnings: Oren's compensation has been consistent with company performance over the past year.

CEO

Oren Shuster (56 yo)

6.6yrs
Tenure
CA$526,397
Compensation

Mr. Oren Shuster serves as the Co-owner of IMC Ltd. Mr. Shuster serves as Chief Executive Officer and Director of IM Cannabis Corp. since October 11, 2019 and also served as Executive Chairman from June 05...

Leadership Team

NamePositionTenureCompensationOwnership
Oren Shuster
CEO & Executive Director6.6yrsCA$526.40k12.36%
$ 221.6k
Asi Levi
Chief Financial Officerless than a yearCA$220.63kno data
Richard Balla
Chief Executive Officer of Adjupharm6.3yrsCA$317.13k0.010%
$ 179.9
Anna Taranko
Director Investor & Public Relationsno datano datano data
Eyal Fisher
Chief Executive Officer of the IMC Holdings3.2yrsCA$297.79kno data
4.8yrs
Average Tenure
45yo
Average Age

Experienced Management: IMCC's management team is considered experienced (4.8 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Oren Shuster
CEO & Executive Director6.6yrsCA$526.40k12.36%
$ 221.6k
Eliyahu Zamir
Directorless than a yearCA$24.15kno data
Mordechai Marcus
Independent Director3.7yrsCA$80.64kno data
Alon Dayan
Directorless than a yearno datano data
Oz Adler
Chairman of the Boardless than a yearCA$111.31kno data
Einat Zakariya
Independent Director3.7yrsCA$76.05k0.16%
$ 2.9k
Asaf Yitzhaik
Directorless than a yearCA$24.15kno data
0.8yrs
Average Tenure
54yo
Average Age

Experienced Board: IMCC's board of directors are not considered experienced ( 0.8 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/05/31 18:04
End of Day Share Price 2026/05/29 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

IM Cannabis Corp. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Aaron GreyAlliance Global Partners